iShares U.S. Pharmaceuticals ETF (IHE) Holdings $66.16 +1.29 (+1.99%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Top 42 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1JNJJohnson & Johnson$154.89-0.3%24.14%909,6962LLYEli Lilly and Company$861.11+3.8%23.05%180,2553RPRXRoyalty Pharma$32.03+1.1%4.86%901,9424ZTSZoetis$152.52+1.1%4.82%183,2585BMYBristol-Myers Squibb$48.66+0.3%4.74%495,3866PFEPfizer$22.80+1.8%4.58%1,152,4377BlackRock Cash Funds Treasury SL AgencyN/A4.54%26,221,4338MRKMerck & Co., Inc.$79.93+1.5%4.48%317,3989VTRSViatris$8.04+2.9%4.23%3,206,55110CORTCorcept Therapeutics$71.79+3.6%3.27%253,969 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11JAZZJazz Pharmaceuticals$108.98+4.6%3.14%164,65212ELANElanco Animal Health$9.45+2.8%2.13%1,346,37213PBHPrestige Consumer Healthcare$79.47-0.4%1.94%134,91714AXSMAxsome Therapeutics$105.41+1.1%1.90%110,87115PRGOPerrigo$24.87+0.5%1.69%371,56416OGNOrganon & Co.$12.12+5.4%1.59%701,40717LGNDLigand Pharmaceuticals$108.55+2.6%0.89%51,45718SUPNSupernus Pharmaceuticals$31.35+1.7%0.85%150,38919TARSTarsus Pharmaceuticals$49.97-0.1%0.77%94,74320ANIPANI Pharmaceuticals$69.64+1.9%0.53%45,20021HRMYHarmony Biosciences$29.43+1.8%0.53%104,07022AMRXAmneal Pharmaceuticals$7.42+1.6%0.52%405,03623PCRXPacira BioSciences$26.00+3.2%0.50%125,75524AMPHAmphastar Pharmaceuticals$24.07+2.2%0.47%102,14725INVAInnoviva$18.38+0.1%0.46%150,04326COLLCollegium Pharmaceutical$26.78+3.0%0.43%87,83227E-MINI HEALTH CARE SECTOR JUN 25N/A0.38%1628OCULOcular Therapeutix$7.90+0.6%0.38%346,82229EWTXEdgewise Therapeutics$15.40+3.8%0.37%188,06830HROWHarrow$25.07+5.2%0.34%83,42031WVEWave Life Sciences$6.790.33%319,84732LQDALiquidia$14.03+3.5%0.29%129,08933ELVNEnliven Therapeutics$18.33+3.2%0.27%82,49734EOLSEvolus$11.55+2.8%0.25%134,51335ARVNArvinas$9.14+0.8%0.20%174,19936NUVBNuvation Bio$2.12+1.9%0.20%694,47537OMEROmeros$7.30+4.7%0.19%157,82138MNMDMind Medicine (MindMed)$6.43+5.2%0.17%179,74539TBPHTheravance Biopharma$9.54+1.0%0.14%95,05040CASH COLLATERAL USD SGAFTN/A0.02%131,000M.A.G.A. is Finished – This Could be even Better (Ad)You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).When you see what could happen – I think you’ll be excited.41Cash OffsetN/A-0.38%2,203,20042USD CASHN/A-4.21%24,302,728 Geographic ExposureUnited States95.0%Ireland4.4%Singapore0.4%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care99.4%Energy0.5%Industry ExposureBiotechnology84.3%Pharmaceuticals14.6%Renewable Energy0.5%Health Care Equipment & Supplies0.5%SubIndustry ExposureBiotechnology80.7%Pharmaceuticals16.8%Renewable Energy Equipment0.5%Health Care Supplies0.5%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies VanEck Pharmaceutical ETF Portfolio Direxion Daily S&P Biotech Bull 3x Shares Portfolio iShares U.S. Healthcare Providers ETF Portfolio VanEck Biotech ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio Invesco Pharmaceuticals ETF Portfolio Invesco Biotechnology & Genome ETF Portfolio First Trust Health Care AlphaDEX Fund Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio This page (NYSEARCA:IHE) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IHE Stock Free IHE Stock Alerts